Please log in to view this page
Username
Password
A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
A5320/V-HICS is an observational, prospective, long-term follow-up study in hepatitis C virus (HCV) monoinfected and HCV/HIV-1...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
